Vered Gigi is a Principal with aMoon Velocity, where she drives due diligence on early-stage companies, with a focus on pharmaceutical and medical device companies.
Prior to joining aMoon, Vered served as Chief Scientific Officer at Cure Pharmaceutical, a drug delivery company in the pharmaceutical & wellness space, and before that as a project leader at BCG Management Consulting in their healthcare practice. Her experience spans strategy, business development, R&D, and operations in both corporate and startup settings.
Vered’s passion is in translating exciting science into therapies in a practical and sustainable fashion. Her experience taught her that not all discoveries are made equal and there is a time and a place for each.
Vered completed her PhD in Immunology at the University of Pennsylvania, where she investigated nucleases and DNA repair mechanisms in the immune system and their contribution to cancer. She holds a BSc and MSc in Biomedical Sciences from Tel Aviv University.
